NCT02446314

Brief Summary

The purpose of this study is to determine whether a 6 month dietary intervention with wild blueberry powder and extract stabilised with L-cysteine and L-glutathione have an effect on cognitive performance in participants aged between 65 - 80.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2015

Completed
4 days until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 18, 2015

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

August 8, 2019

Completed
Last Updated

August 8, 2019

Status Verified

June 1, 2019

Enrollment Period

1.5 years

First QC Date

April 27, 2015

Results QC Date

October 10, 2018

Last Update Submit

June 24, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Proportion of Words Correctly Recognised.

    Participants indicate whether words presented on a monitor are from a list of 15 words previously presented auditorily (via headphones), or if they are novel foils.

    12, and 24 weeks

  • Total Number of Correct Sequences Recalled

    Participants view an array of 9 white squares on a monitor which light up red in sequences of between 2 and 9. They are then required to press the correct squares in the sequence they were presented.

    12, and 24 weeks

  • Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.

    Combined Z score of proportion of words recalled, proportion of words recognised, and proportion of pictures recognised. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome

    12, and 24 weeks

Secondary Outcomes (7)

  • Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.

    12, and 24 weeks

  • Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line

    12, and 24 weeks

  • Systolic Blood Pressure

    12, and 24 weeks.

  • Diastolic Blood Pressure

    12, and 24 weeks

  • Heart Rate

    12, and 24 weeks.

  • +2 more secondary outcomes

Study Arms (4)

Placebo

PLACEBO COMPARATOR

Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen

Dietary Supplement: Placebo

Wild Blueberry Powder - 450mg

EXPERIMENTAL

Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen

Dietary Supplement: Wild Blueberry Powder - 450mg

Wild Blueberry Powder - 900 mg

EXPERIMENTAL

Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen

Dietary Supplement: Wild Blueberry Powder - 900 mg

Wild Blueberry extract 100mg

EXPERIMENTAL

Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen

Dietary Supplement: Wild Blueberry extract 100mg

Interventions

PlaceboDIETARY_SUPPLEMENT

Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen

Placebo

Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen

Wild Blueberry Powder - 450mg

Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen

Wild Blueberry Powder - 900 mg

Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen

Wild Blueberry extract 100mg

Eligibility Criteria

Age65 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Overall healthy volunteers as proven by medical history and/or physical examination and of all ethnicity and socioeconomic status
  • Free-living
  • Subjects with subjective memory complaints
  • MMSE: 24-30
  • Subjects are willing to maintain their normal eating habits and exercise habits to avoid changes in body weight over the duration of the study
  • Being willing to complete the food diaries and questionnaires
  • Able to give signed written informed consent
  • Signed informed consent form

You may not qualify if:

  • Use of complementary and alternative medicine
  • History of metabolic disorder, diabetes, substance abuse
  • Subjects diagnosed with psychiatric or neurological conditions
  • Subjects using medications that might affect the outcome measures (such as antidepressant and sleeping medication), or planned changes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Reading

Reading, Berkshire, RG6 6AH, United Kingdom

Location

Related Publications (6)

  • How, P.S., Ellis, J.A., Neshatdoust, S., Spencer, J.P.E. (2008). The impact of plant-derived flavonoids on mood, memory and motor skills in healthy older UK adults. Proceedings of the Nutrition Society, 67, E316.

    BACKGROUND
  • Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, Joseph JA. Blueberry supplementation improves memory in older adults. J Agric Food Chem. 2010 Apr 14;58(7):3996-4000. doi: 10.1021/jf9029332.

    PMID: 20047325BACKGROUND
  • Macready AL, Kennedy OB, Ellis JA, Williams CM, Spencer JP, Butler LT. Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr. 2009 Dec;4(4):227-42. doi: 10.1007/s12263-009-0135-4. Epub 2009 Aug 13.

    PMID: 19680703BACKGROUND
  • Rendeiro C, Vauzour D, Kean RJ, Butler LT, Rattray M, Spencer JP, Williams CM. Blueberry supplementation induces spatial memory improvements and region-specific regulation of hippocampal BDNF mRNA expression in young rats. Psychopharmacology (Berl). 2012 Oct;223(3):319-30. doi: 10.1007/s00213-012-2719-8. Epub 2012 May 9.

    PMID: 22569815BACKGROUND
  • Rendeiro C, Vauzour D, Rattray M, Waffo-Teguo P, Merillon JM, Butler LT, Williams CM, Spencer JP. Dietary levels of pure flavonoids improve spatial memory performance and increase hippocampal brain-derived neurotrophic factor. PLoS One. 2013 May 28;8(5):e63535. doi: 10.1371/journal.pone.0063535. Print 2013.

    PMID: 23723987BACKGROUND
  • Whyte AR, Cheng N, Fromentin E, Williams CM. A Randomized, Double-Blinded, Placebo-Controlled Study to Compare the Safety and Efficacy of Low Dose Enhanced Wild Blueberry Powder and Wild Blueberry Extract (ThinkBlue) in Maintenance of Episodic and Working Memory in Older Adults. Nutrients. 2018 May 23;10(6):660. doi: 10.3390/nu10060660.

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Results Point of Contact

Title
Prof Claire Williams
Organization
The University of Reading

Study Officials

  • Claire M Williams, PhD

    University of Reaiding

    PRINCIPAL INVESTIGATOR
  • Emilie Fromentin, PhD

    NATURIEX-DBS,, LLC

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor in Behavioural Neuroscience

Study Record Dates

First Submitted

April 27, 2015

First Posted

May 18, 2015

Study Start

May 1, 2015

Primary Completion

November 1, 2016

Study Completion

July 1, 2017

Last Updated

August 8, 2019

Results First Posted

August 8, 2019

Record last verified: 2019-06

Locations